Bone Marrow Transplantation - Table of Contents alert Volume 51 Issue 5

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 51, Issue 5 (May 2016) In this issue Obituary Reviews Commentaries Original Articles Letters to the Editor Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement The Fred Hutchinson Cancer Research Center (FHCRC) and the University of Washington (UW) Department of Medicine are jointly recruiting full-time faculty at the Assistant, Associate, or Full Member level and at the Assistant (0113), Associate (0112) or Full Professor (0111) level without tenure due to funding (WOT), on the Physician/Scientist & Clinician-Scholar/Clinician-Teacher pathways   Advertisement BJC collections: Cancer Immunotherapy Immunotherapies have revolutionised therapy for some cancers. In parallel with therapeutic trials, many other mechanisms and pathways are being investigated in optimising these treatments.  Access this collection from British Journal of Cancer - free online for six months Produced with support from: EMD Serono     Obituary Top Paul I Terasaki (10 September, 1929–25 January, 2016) R P Gale and G Opelz Bone Marrow Transplant 2016 51: 621-622; 10.1038/bmt.2016.70 Full Text Reviews Top Process of allogeneic hematopoietic cell transplantation decision making for older adults J Randall, K Keven, T Atli and C Ustun Bone Marrow Transplant 2016 51: 623-628; advance online publication, October 12, 2015; 10.1038/bmt.2015.241 Abstract | Full Text Invariant natural killer T cells in hematopoietic stem cell transplantation: killer choice for natural suppression P Guan, H Bassiri, N P Patel, K E Nichols and R Das Bone Marrow Transplant 2016 51: 629-637; advance online publication, February 15, 2016; 10.1038/bmt.2015.335 Abstract | Full Text Commentaries Top Rehabilitation need and referrals in hematopoietic stem cell transplantation: the experience of Quality of Life Working Party of the Rome Transplant Network A Tendas, L Cupelli, M R Mauroni, F Sollazzo, F Di Piazza, D Saltarelli, I Carli, A Chierichini, C Melfa, M Surano, O Annibali, M Piedimonte, E Conte, F Marchesi, C Viggiani, A C Pignatelli, T Dentamaro, P Niscola, P de Fabritiis, A P Perrotti and W Arcese on behalf of the Quality of Life Working Party of the Rome Transplant Network Bone Marrow Transplant 2016 51: 638-639; advance online publication, January 11, 2016; 10.1038/bmt.2015.341 Full Text Prophylactic donor lymphocyte infusion in patients with high-risk acute myeloid leukemia: ready for prime time? F Baron and Y Beguin Bone Marrow Transplant 2016 51: 640-642; advance online publication, March 14, 2016; 10.1038/bmt.2016.38 Full Text Hematopoietic cell transplantation in older adults: deciding or decision-making? A S Artz and S Chow Bone Marrow Transplant 2016 51: 643-644; advance online publication, April 4, 2016; 10.1038/bmt.2016.86 Full Text Original Articles Top ACUTE LEUKEMIA Comparable outcomes between autologous and allogeneic transplant for adult acute myeloid leukemia in first CR M Mizutani, M Hara, H Fujita, J Aoki, H Kanamori, K Ohashi, K Usuki, T Fukuda, T Chou, J Tanaka, Y Atsuta and A Takami Bone Marrow Transplant 2016 51: 645-653; advance online publication, January 25, 2016; 10.1038/bmt.2015.349 Abstract | Full Text LYMPHOMA Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas F Heinzelmann, W Bethge, D W Beelen, M Engelhard, N Kröger, P Dreger, D Niederwieser, J Finke, D Bunjes, J Tischer, G Kobbe, E Holler, M Bornhäuser, M Stelljes, H Baurmann, A Müller, I Haubitz, H Schrezenmeier, C Müller and H Ottinger Bone Marrow Transplant 2016 51: 654-662; advance online publication, February 8, 2016; 10.1038/bmt.2015.348 Abstract | Full Text CELLULAR THERAPY Long-term results of adjuvant donor lymphocyte transfusion in AML after allogeneic stem cell transplantation Z Jedlickova, C Schmid, C Koenecke, B Hertenstein, H Baurmann, R Schwerdtfeger, J Tischer, H-J Kolb and M Schleuning Bone Marrow Transplant 2016 51: 663-667; advance online publication, October 5, 2015; 10.1038/bmt.2015.234 Abstract | Full Text GRAFT MANIPULATION TCR-alpha/beta and CD19 depletion and treosulfan-based conditioning regimen in unrelated and haploidentical transplantation in children with acute myeloid leukemia M Maschan, L Shelikhova, M Ilushina, E Kurnikova, E Boyakova, D Balashov, M Persiantseva, Y Skvortsova, A Laberko, Y Muzalevskii, A Kazachenok, S Glushkova, V Bobrynina, V Kalinina, Y Olshanskaya, D Baidildina, G Novichkova and A Maschan Bone Marrow Transplant 2016 51: 668-674; advance online publication, January 25, 2016; 10.1038/bmt.2015.343 Abstract | Full Text HISTOCOMPATIBILITY AND DONOR SELECTION ISSUES Consideration of noninherited maternal Ags as permissible HLA mismatches in cord blood donor selection L Powley, C Brown, A Melis, Y Li, G Parkes and C V Navarrete Bone Marrow Transplant 2016 51: 675-679; advance online publication, January 25, 2016; 10.1038/bmt.2015.344 Abstract | Full Text TRANSPLANT TOXICITIES Adverse reactions during stem cell infusion in children treated with autologous and allogeneic stem cell transplantation T H Truong, R Moorjani, D Dewey, G M T Guilcher, N L Prokopishyn and V A Lewis Bone Marrow Transplant 2016 51: 680-686; advance online publication, January 11, 2016; 10.1038/bmt.2015.331 Abstract | Full Text Risk factors and outcome of graft failure after HLA matched and mismatched unrelated donor hematopoietic stem cell transplantation: a study on behalf of SFGM-TC and SFHI T Cluzeau, J Lambert, N Raus, K Dessaux, L Absi, F Delbos, A Devys, M De Matteis, V Dubois, M Filloux, M Fort, F Hau, I Jollet, M Labalette, D Masson, B Mercier, B Pedron, P Perrier, C Picard, F Quainon, A Ramounau-Pigot, V Renac, P Van Endert, D Charron, R Peffault de la Tour, J L Taupin and P Loiseau Bone Marrow Transplant 2016 51: 687-691; advance online publication, February 8, 2016; 10.1038/bmt.2015.351 Abstract | Full Text GRAFT-VERSUS-HOST DISEASE Conjunctival polyploid cells and donor-derived myofibroblasts in ocular GvHD D Hallberg, K Stenberg, C Hanson, U Stenevi and M Brune Bone Marrow Transplant 2016 51: 692-697; advance online publication, January 25, 2016; 10.1038/bmt.2015.347 Abstract | Full Text Improved outcome of children transplanted for high-risk leukemia by using a new strategy of cyclosporine-based GVHD prophylaxis N Bleyzac, D Cuzzubbo, C Rénard, N Garnier, V Dubois, C Domenech, M-P Goutagny, A Plesa, N Grardel, S Goutelle, A Janoly-Duménil and Y Bertrand Bone Marrow Transplant 2016 51: 698-704; advance online publication, January 25, 2016; 10.1038/bmt.2015.350 Abstract | Full Text Prevalence and determinants of fatigue in patients with moderate to severe chronic GvHD A Im, S A Mitchell, S M Steinberg, L Curtis, A Berger, K Baird, Z Kuzmina, G Joe, L E Comis, M Juckett, D Avila, J Baruffaldi, L Masuch, F Pirsl and S Z Pavletic Bone Marrow Transplant 2016 51: 705-712; advance online publication, February 1, 2016; 10.1038/bmt.2015.320 Abstract | Full Text INFECTIONS Risk factors for recurrent Clostridium difficile infection in allogeneic hematopoietic cell transplant recipients S Mani, L Rybicki, D Jagadeesh and S B Mossad Bone Marrow Transplant 2016 51: 713-717; advance online publication, January 4, 2016; 10.1038/bmt.2015.311 Abstract | Full Text Letters to the Editor Top Preemptive antiviral therapy for CMV infection in allogeneic stem cell transplant recipients guided by the viral doubling time in the blood C Solano, E Giménez, J L Piñana, V Vinuesa, S Poujois, S Zaragoza, M Calabuig and D Navarro Bone Marrow Transplant 2016 51: 718-721; advance online publication, December 7, 2015; 10.1038/bmt.2015.303 Full Text Impact of a lifestyle modification program on the metabolic syndrome and associated risk factors in long-term survivors of stem cell transplantation E Viner Smith, A C Tierney, D Klarica, P Walker and S Avery Bone Marrow Transplant 2016 51: 722-724; advance online publication, December 21, 2015; 10.1038/bmt.2015.312 Full Text Pretransplant mogamulizumab against ATLL might increase the risk of acute GVHD and non-relapse mortality Y Inoue, S Fuji, R Tanosaki and T Fukuda Bone Marrow Transplant 2016 51: 725-727; advance online publication, December 21, 2015; 10.1038/bmt.2015.315 Full Text Extracorporeal photopheresis as a new supportive therapy for bronchiolitis obliterans syndrome after allogeneic stem cell transplantation C Del Fante, T Galasso, P Bernasconi, L Scudeller, F Ripamonti, C Perotti and F Meloni Bone Marrow Transplant 2016 51: 728-731; advance online publication, January 4, 2016; 10.1038/bmt.2015.324 Full Text Outcomes of autologous hematopoietic cell transplantation in primary amyloidosis after bortezomib-based induction therapy S Hong, J Valent, L Rybicki, D Abounader, B Bolwell, R Dean, A T Gerds, D Jagadeesh, B K Hamilton, B Hill, M E Kalaycio, B Pohlman, F Reu, C Samaras, R Sobecks, N S Majhail and H D Liu Bone Marrow Transplant 2016 51: 732-734; advance online publication, January 4, 2016; 10.1038/bmt.2015.326 Full Text Treatment of hepatitis C in a pediatric patient using simeprevir and sofosbuvir immediately after an umbilical cord blood transplantation P Thomas, T Santiago and M H Dallas Bone Marrow Transplant 2016 51: 735-737; advance online publication, January 11, 2016; 10.1038/bmt.2015.309 Full Text Early changes in bone mineral density and trabecular bone score following allogeneic stem cell transplant M Pawlowska, Q Yang, B Hamata, D L Kendler and R Broady Bone Marrow Transplant 2016 51: 738-740; advance online publication, January 11, 2016; 10.1038/bmt.2015.329 Full Text Phosphorylated STAT3 expression in hematopoietic stem cell transplant-associated large granular lymphocytic leukemia C S Liang, A E Quesada, M Goswami, P K Johnston, R E Brown and J M Jaso Bone Marrow Transplant 2016 51: 741-743; advance online publication, January 11, 2016; 10.1038/bmt.2015.336 Full Text Reduced intensity conditioning regimen with fludarabine, cyclophosphamide, low dose TBI and alemtuzumab leading to successful unrelated umbilical cord stem cell engraftment and survival in two children with dyskeratosis congenita M Brown, D Myers, N Shreve, R Rahmetullah and M Radhi Bone Marrow Transplant 2016 51: 744-746; advance online publication, January 25, 2016; 10.1038/bmt.2015.333 Full Text Astrovirus outbreak at a pediatric hematology and hematopoietic stem cell transplant unit despite strict hygiene rules H P J van der Doef, E Bathoorn, M P M van der Linden, T F W Wolfs, A L C Minderhoud, M B Bierings, A M J Wensing and C A Lindemans Bone Marrow Transplant 2016 51: 747-750; advance online publication, January 25, 2016; 10.1038/bmt.2015.337 Full Text Is allogeneic transplant for solid tumors still alive? M Bregni, M Badoglio, P Pedrazzoli and F Lanza on behalf of the STWP of the EBMT Bone Marrow Transplant 2016 51: 751-752; advance online publication, January 25, 2016; 10.1038/bmt.2015.345 Full Text TCR αβ and CD19-depleted haploidentical stem cell transplant with reduced intensity conditioning for Hoyeraal–Hreidarsson syndrome with RTEL1 mutation R Bhattacharyya, A M Tan, M Y Chan, S S Jamuar, R Foo and P Iyer Bone Marrow Transplant 2016 51: 753-754; advance online publication, January 25, 2016; 10.1038/bmt.2015.352 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.